 |
 |
 |
 |
 |
 |
 |
 |
 |
Results for 'Indian Pharmaceutical Industry' |
|
|
| Title |
 |
Publication Date |
 |
Price |
 |
Relevance |
 |

|
|
|
|
Indian Pharmaceutical Industry, The:
|
March 2005 |
£3335 |
99 % |
Indian Pharmaceutical Industry
|
July 2008 |
£1695 |
50 % |
Indian Bioinformatics Industry
|
April 2004 |
£550 |
35 % |
Indian Pharmaceutical and Healthcare Market Annual Review
2005
|
May 2005 |
£745 |
31.15 % |
Industry Insight Clinical Trials in India 2007
|
May 2007 |
£400 |
31 % |
Indian Bulk Drug Industry Insight 2007
|
May 2007 |
£400 |
30.45 % |
Indian Pharmaceuticals: Industry Insight
Industry Insight
|
April 2005 |
£400 |
30 % |
Kazakhstan: Country Scan
|
October 2004 |
£40 |
29.05 % |
Japan: Country Scan
|
December 2004 |
£40 |
29.05 % |
Argentina: Country Scan
|
September 2004 |
£40 |
29.05 % |
South Korea: Country Scan
|
July 2004 |
£40 |
29.05 % |
Taiwan: Country Scan
|
March 2004 |
£40 |
29.05 % |
Chile: Country Scan
Country Scan
|
June 2005 |
£100 |
29.05 % |
Poland: Country Scan
|
February 2004 |
£40 |
29.05 % |
Thailand: Country Scan
|
April 2004 |
£40 |
29.05 % |
Philippines: Country Scan
Country Scan
|
February 2005 |
£100 |
29.05 % |
Singapore: Country Scan
Country Scan
|
February 2005 |
£100 |
29.05 % |
The Indian Pharmaceutical Directory 2007
How to keep up-to-date with India's Pharmaceutical businesses and discover thousands of new business leads
|
August 2007 |
£170 |
29 % |
Indian Generics, 2008-2012
A Growing Threat to Westernised Markets
|
January 2008 |
£1600 |
28.7 % |
India Pharmaceuticals & Healthcare
|
September 2007 |
£360 |
28 % |
Indian Pharmaceutical Market, 2006-2011
|
June 2006 |
£1499 |
26.95 % |
India Pharmaceuticals and Healthcare Report Q3 2008
|
July 2008 |
£425 |
26.25 % |
Indian Healthcare Services Industry Report
|
January 2007 |
£400 |
26 % |
Latin American Market for Generic Drugs; The
|
April 2006 |
£995 |
25.2 % |
Guide to Pharmaceutical Outsourcing in China
|
February 2008 |
£1515 |
23.45 % |
Japan Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
23.45 % |
Opportunities in Indian Pharma Sector
|
July 2006 |
£350 |
23.1 % |
The Indian Pharmaceutical Market to 2011
Competitive dynamics and major players
|
July 2007 |
£1495 |
22.75 % |
Japan Pharmaceuticals & Healthcare
|
September 2007 |
£360 |
22.75 % |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£600 |
22.75 % |
Indian Biopharmaceuticals
|
January 2008 |
£600 |
22.05 % |
Contract Research and Manufacturing Services
India (CRAMS)
|
March 2008 |
£600 |
21.7 % |
Research & Development in the Pharmaceutical Industry
Options for success
|
February 2004 |
£825 |
20.3 % |
Indian Medical Market Report
2005
|
May 2005 |
£1110 |
20.3 % |
Indian Biopharmaceuticals Industry Report
|
January 2007 |
£400 |
19.6 % |
Achieving success in the Developing Asian Pharmaceutical Sector 2007-2011
|
November 2006 |
£1999 |
19.25 % |
Global Generics Industry Report
|
September 2006 |
£550 |
18.55 % |
Indian Pharmaceutical Market, The
Challenges & Opportunities
|
February 2007 |
£595 |
18 % |
Asia Generic Pharmaceuticals Forecast Report; The
|
July 2006 |
£510 |
17.15 % |
Johnson & Johnson Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£67 |
17.15 % |
Contract Manufacturing Strategies: Market developments, technology transfer and key success factors
|
May 2008 |
£1995 |
17.15 % |
Booming Clinical Trials Market in India
|
November 2007 |
£595 |
17 % |
Booming Biotech Market in India
|
June 2008 |
£705 |
16.8 % |
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
16.5 % |
Healthcare and Pharmaceuticals in Latin America
A guide to the markets and regulations
|
May 2005 |
£525 |
16.45 % |
Brazil Pharmaceuticals & Healthcare Report Q3 2006
|
July 2006 |
£395 |
15.05 % |
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
|
May 2008 |
£1499 |
15.05 % |
Pharmaceutical Regulatory Affairs in The Eu & US
|
January 2006 |
£1095 |
15 % |
World Market for Prescription Generic Drugs
6th Edition
|
April 2008 |
£2015 |
14.7 % |
Outsourcing Clinical Trials
A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
|
May 2007 |
£1515 |
14.35 % |
Wockhardt Generics Company Intelligence Report
Company Intelligence Report
|
June 2008 |
£195 |
13.5 % |
US and European Prescription Generic Markets
An Examination of Commercial and Regulatory Contrasts
|
September 2005 |
£745 |
13.3 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
12.6 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
12.6 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
12.6 % |
Generic Option; The
|
July 2006 |
£440 |
12.6 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
12.6 % |
The Outlook for Pharmaceuticals in Central Asia
|
March 2007 |
£1995 |
12 % |
Indian Healthcare - New Avenues for Growth
|
October 2008 |
£435 |
11.9 % |
Clinical Trials Market 2006, The
|
February 2006 |
£1499 |
11.9 % |
Bioinformatics Report
The forecasts and future of the market 2006-2011
|
October 2006 |
£1499 |
11.9 % |
Emerging Pharmaceutical Markets
Potential & Problems
|
September 2000 |
£195 |
11.9 % |
Latin American Market for Generic Drugs; The
|
April 2006 |
£995 |
11.5 % |
Pharmaceutical Pricing: global perspectives
|
September 2004 |
£625 |
11.2 % |
The Pharmaceutical Industry 2008
Current and Future Trends and Strategic Issues Shaping Pharma
|
March 2008 |
£2995 |
10.85 % |
World Generics Market 2006-2011; The
|
May 2006 |
£1499 |
10.5 % |
Bahrain Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
10.5 % |
Outsourcing in Drug Discovery, 3rd Edition
|
May 2008 |
£1510 |
8.05 % |
Clinical Trials Business; The
|
August 2006 |
£2410 |
7.7 % |
Russia Pharmaceuticals & Healthcare
|
July 2006 |
£395 |
7.5 % |
Poland Pharmaceuticals and Healthcare Report Q3 2006
|
July 2006 |
£395 |
7.5 % |
ADME/TOX Technologies
|
January 2008 |
£1450 |
6.65 % |
High Throughput Screening
|
January 2008 |
£1525 |
6.65 % |
World Generic Market Report 2007
|
November 2006 |
£595 |
5.95 % |
Animal Biotechnology
Technologies, Markets and Companies
|
September 2008 |
£1340 |
5.6 % |
Incremental Improvements And Paradigm Shifts In Strategy Are Both Necessary To Boost Productivity
R&D Strategies
|
August 2007 |
£7600 |
5.25 % |

|
|
|
|